VAM26 offers multiple opportunities for you to share your work, ideas and research — whether through education sessions, abstracts, posters or named lectures.
Explore the different pathways below to becoming a podium or poster presenter!
| Type | Submission Window |
|---|---|
Education Sessions
Education SessionsThe VAM Education Sessions occur in programs of varying sizes, taking formats such as small group interactive lectures, case-based courses, hands-on, and innovative/non-didactic approaches.
Note: SVS Sections Sessions and Resident and Student Session programs do not need to officially submit for their existing timeslot; please work directly with your SVS staff liaisons. If the Section or RSOC programming wishes to have additional time, please submit another proposal.
Total number of sessions within VAM: 18-22 |
July 16 – Aug. 20 SUBMISSIONS CLOSED |
Hot Topics
New for VAM26: Hot Topics
Total number of sessions within VAM: 1 |
Sept. 17 – Oct. 15 SUBMISSIONS CLOSED |
Plenary Sessions & Posters
Plenary Sessions and PostersAbstracts are intended primarily for the presentation of scientific research in various topic areas. Plenary Session
Submission window: Nov. 12 - Jan. 7, 2026 Posters
Submission window: Nov. 12 - Jan. 7, 2026 |
Nov. 12 – Jan. 7, 2026 SUBMISSIONS CLOSED |
Videos
VideosSubmit a video showcasing a novel/unique approach, or a core vascular surgical procedure
Submission window: Nov. 12 - Jan. 7, 2026 |
Nov. 12 – Jan. 7, 2026 SUBMISSIONS CLOSED |
SVS-VESS Scientific Sessions
SVS-VESS Scientific Sessions
Submission window: Nov. 12 - Jan. 7, 2026 |
Nov. 12 – Jan. 7, 2026 SUBMISSIONS CLOSED |
International Plenary/Young Surgeons Competition
International Plenary Session and International Young Surgeons Competition
Submission window: Nov. 12 - Jan. 7, 2026 |
Nov. 12 – Jan. 7, 2026 SUBMISSIONS CLOSED |
Late-Breaking Abstracts
Late-Breaking AbstractsSubmit NowDeadline: Feb 25 | 3:00 p.m. CSTOverviewThe Society for Vascular Surgery (SVS) invites authors to submit late breaking abstracts for the 2026 Vascular Annual Meeting (VAM26). This premier event in the field of vascular surgery will feature the latest advancements in vascular medicine and offer a platform for researchers and practitioners to share their innovative work. Late Breaking Abstracts are innovative and provide the latest breakthroughs in clinical science. The sessions provide exposure and recognition for studies likely to have a significant impact on clinical practice and/or to make significant advances in a scientific field. They must highlight important results obtained after the January 7th abstract submission deadline. We will not be accepting duplicate abstract submissions from the call for abstracts that took place November 2025-January 2026. Authors are encouraged to review the following guidelines to ensure their submissions meet all requirements.
You must identify the following roles during the submission process
Submitting Author
The author who enters the abstract information into the online system. All administrative correspondence regarding the submission will be sent to this individual.
Presenting Author
The author who will present the submission on-site during the session.
Submitting and Presenting Author
The author who will both enter the abstract information into the online system and present the material on-site during the session.
Co-Author
An individual who has contributed data or other information to the submission.
Senior Author
The author who is primarily responsible for the research.
Senior Author Discussant
If the author presenting the paper is a medical student or trainee, a Senior Author Discussant will be identified and present at the podium during the presentation to answer questions on the abstract.
Abstract Submission Compliance RequirementsTo ensure a fair and unbiased review process, please refrain from including any identifying information in your submission. This includes, but is not limited to:
Submissions that include identifying information may be returned for revisions or disqualified from the review process. Do not use proprietary drug names in your abstract body or title; use generic names instead (e.g., "Herceptin” should be written as "trastuzumab"). If the proprietary name is the only one used for the particular drug or product to which you are referring (e.g., HercepTest or CyberKnife), you may use that name; however, do not include a trademark or registration symbol. The work represented in the abstract must NOT have been presented nor published at any scientific meeting or journal prior to that year’s Vascular Annual Meeting. Failure to comply with the above rules will result in the abstract being rejected or later withdrawn. In addition, the penalty may include a one-year ban from presentation at the Vascular Annual Meeting, subject to the discretion of the Program Committee. It is the responsibility of the submitting author or sponsoring SVS member to consult with the Program Committee prior to submission if there is any question regarding possible redundancy of the work to be presented. Direct inquiries to vameducation@vascularsociety.org. Questions?Contact vameducation@vascularsociety.org with questions. |
Jan. 28, 2026 – Feb. 25, 2026 |
There are annually three invited/named sessions that occur during the VAM. They include:
Note: The topics for the invited sessions are selected by the SVS Leadership.